# Efficiency Report — MISSION-001 M1 Cycle
Date: 2026-05-07
Eval window: 2026-05-07 to 2026-05-08
Prepared by: Eval Agent

---

## Executive Summary

M1 shipped ahead of the 2026-05-10 target — a strong velocity result for a day-one sprint. Architect and UI/UX produced high-quality, actionable deliverables. The primary harness concern is in the Instruction layer: SE's protocol adherence was weak (empty MEMORY.md, undocumented architecture deviation to SQLite, CPE had to step in to fix a build blocker), and M1 was flagged complete before the Vercel production deployment — which means QA is testing on localhost rather than the required production environment. CPE also crossed the implementation boundary by fixing the Prisma config directly rather than routing to SE, and left the resolved P1 bug open in the active bug log.

---

## Agent Performance Scores

| Agent | Accuracy | Protocol | Output Quality | Velocity | Self-Verify | Overall | Trend |
|-------|----------|----------|----------------|----------|-------------|---------|-------|
| CPE | 4/5 | 3/5 | 4/5 | 5/5 | N/A | 3.85/5 | → (first cycle) |
| Software Engineer | 3/5 | 2/5 | 3/5 | 3/5 | 2/5 | 2.70/5 | → (first cycle) |
| QA Engineer | N/A | N/A | N/A | N/A | N/A | N/A | (not yet tested) |
| Architect | 4/5 | 5/5 | 4/5 | 5/5 | N/A | 4.35/5 | → (first cycle) |
| UI/UX Engineer | — | — | — | — | — | — | (no criteria defined; see notes) |

Score definitions: see EVAL_CRITERIA.md
Weights: CPE (30/30/25/15%), SE (35/20/25/10/10%), Architect (35/20/30/15%)

---

## Issues Identified

### Issue 1: SE MEMORY.md left entirely blank
- **Agent:** Software Engineer
- **Dimension:** Protocol Adherence
- **Score impact:** Contributes to 2/5 on Protocol
- **Observed:** SE MEMORY.md (`missions/active/MISSION-001-link-vault/.agents/se/MEMORY.md`) contains zero entries. All sections (decisions, surprises, open questions, handoff state) are empty, despite SE encountering a build blocker (Prisma adapter issue) and making an undocumented architectural deviation (SQLite).
- **Root cause:** SE AGENTS.md likely lacks an explicit trigger that mandates MEMORY.md updates during the build phase. The CPE handoff says to "log blockers in `.agents/se/MEMORY.md`" but this instruction may not be reflected in the agent's own protocol.
- **Finding type:** INSTANCE (missing in this session) + PATTERN (first sign of a protocol gap that will recur)
- **Impact:** No session continuity. If SE restarts M2 with a new context window, they have no record of the SQLite deviation, the Prisma fix, or any decisions made during M1. Risk of repeating the same configuration mistake.
- **Recommendation (instance):** Patch SE AGENTS.md §Build Phase Protocol: add "Update MEMORY.md whenever you make a decision, discover a surprise, or hit a blocker — minimum once per phase. If escalating to CPE, write the issue to MEMORY.md first."
- **Recommendation (pattern):** Update agent-development skill §Agent Memory Protocol: all build-phase agents (SE, QA) must have an explicit MEMORY.md update step in their per-phase checklist.

---

### Issue 2: Undocumented architecture deviation — SQLite instead of PostgreSQL
- **Agent:** Software Engineer
- **Dimension:** Accuracy, Protocol Adherence
- **Score impact:** Contributes to 3/5 Accuracy, 2/5 Protocol
- **Observed:** Architecture and ExecPlan specify PostgreSQL throughout. SE used SQLite for local dev (`provider = "sqlite"`, `url = "file:./prisma/dev.db"`). As a result, the tags field changed from `String[]` (PostgreSQL native array) to `String` (JSON-serialized string workaround) — a schema deviation not present in the ExecPlan. No decision was logged in MEMORY.md or signaled to CPE.
- **Root cause:** ExecPlan didn't explicitly address local dev database choice. "Create Railway PostgreSQL database (free tier)" assumes the developer sets up Railway from day one, but doesn't say "do not use SQLite." When SE chose the pragmatic SQLite path, there was no protocol gate requiring an architecture deviation to be logged.
- **Finding type:** INSTANCE (SQLite choice for this mission) + PATTERN (any mission where ExecPlan doesn't specify local dev setup explicitly)
- **Impact:** QA is testing on SQLite behavior, not PostgreSQL. The tags schema change (`String` vs `String[]`) must be addressed before Vercel deployment to PostgreSQL. Risk of schema migration surprises. Production migration of the tags field will require a data migration step that doesn't exist yet.
- **Recommendation (instance):** Patch SE AGENTS.md §Architecture Compliance: "Any deviation from the ExecPlan's specified database, library, or schema requires (1) a logged decision in MEMORY.md with rationale, and (2) a signal to CPE before proceeding."
- **Recommendation (pattern):** Update Architect AGENTS.md §ExecPlan Standards: "For database setup, specify explicitly: (1) what provider to use for local dev, (2) whether local dev mirrors production exactly, (3) what to do if not. Pin exact dependency versions for ORM and database drivers."

---

### Issue 3: M1 marked complete without Vercel production deployment
- **Agent:** CPE and Software Engineer
- **Dimension:** Accuracy (CPE), Accuracy (SE)
- **Score impact:** Contributes to 4/5 CPE Accuracy, 3/5 SE Accuracy
- **Observed:** M1 acceptance criteria in PLANS.md require "Vercel deployment successful" and "All endpoints tested in production." QA handoff (`20260508-CPE-QA-m1-testing.md`) directs QA to test at `http://localhost:3001`, not a Vercel URL. PROGRESS.md logs M1 as "✓ Complete" without a Vercel deployment URL.
- **Root cause:** Prisma blocker resolution consumed the deployment window. CPE approved M1 and routed to QA after the Prisma fix, without verifying all acceptance criteria. Timeline pressure likely a factor.
- **Finding type:** INSTANCE
- **Impact:** QA may pass tests that fail in the Vercel environment (environment variable injection, SQLite→PostgreSQL schema differences, Vercel cold start behavior). Production issues could surface post-M1 sign-off, requiring a re-test cycle that eats into the M2 schedule.
- **Recommendation (instance):** Patch CPE AGENTS.md §Milestone Sign-Off Protocol: "Before routing to QA, verify all acceptance criteria in PLANS.md are satisfied. M1 includes production deployment — do not route to QA if deployment is incomplete. If time pressure forces a deviation, document it explicitly in PROGRESS.md and scope QA's test window accordingly."

---

### Issue 4: CPE crossed implementation boundary — fixed code directly
- **Agent:** CPE
- **Dimension:** Protocol Adherence
- **Score impact:** Contributes to 3/5 Protocol
- **Observed:** CPE "fixed Prisma 7 config issue resolved by downgrading to v5" (per PROGRESS.md). CPE directly modified implementation dependencies rather than routing the bug back to SE via the standard bug-fix loop. No entry in `docs/decisions/`. SE MEMORY.md not updated with the fix.
- **Root cause:** Timeline pressure + pragmatic judgment that a config issue was faster for CPE to resolve directly. The chain-of-command protocol (CPE routes, SE fixes) has no explicit exception for "trivial config fixes." This created a gap.
- **Finding type:** INSTANCE (specific fix) + PATTERN (CPE intervening in SE implementation under time pressure — will recur on aggressive timelines)
- **Impact:** (1) SE has no record of the fix; if Prisma version or adapter issues recur, SE starts from scratch. (2) The fix bypassed QA verification of the change. (3) SE doesn't practice resolving this class of error. (4) If this pattern repeats, SE's skills atrophy on configuration issues because CPE handles them.
- **Recommendation (instance):** Patch CPE AGENTS.md §Blocker Resolution: "If CPE personally resolves a technical issue (rather than routing to SE): (1) Create a decision entry in docs/decisions/, (2) Update SE MEMORY.md with what was fixed and how, (3) Move bug from bug-log/active/ to bug-log/resolved/ and mark CPE-resolved, (4) Route SE a brief summary so they learn the fix."

---

### Issue 5: Resolved P1 bug left open in bug-log/active/
- **Agent:** CPE
- **Dimension:** Protocol Adherence
- **Score impact:** Secondary contribution to 3/5 Protocol
- **Observed:** `missions/.../bug-log/active/20260507-P1-prisma-nextjs-build-config.md` is marked OPEN even though CPE resolved the issue (downgraded Prisma to v5). The active bug-log now has a ghost entry that QA will encounter.
- **Root cause:** No protocol for CPE to close/move bug tickets when fixing them directly (outside the standard SE→QA resolution loop).
- **Finding type:** INSTANCE
- **Impact:** QA opens their first session, reads bug-log/active/, and finds an OPEN P1 that's already resolved. Risk of wasted effort or confusion.
- **Recommendation (instance):** Same as Issue 4 point (3) above. Additionally, patch CPE AGENTS.md §Bug Log Hygiene: "When a bug is resolved by any path (SE fix or CPE fix), move it from bug-log/active/ to bug-log/resolved/ and update Status to RESOLVED in the bug header."

---

### Issue 6: SE self-verification gap — build blocker not caught before signaling complete
- **Agent:** Software Engineer
- **Dimension:** Self-Verification
- **Score impact:** 2/5 Self-Verify
- **Observed:** The Prisma v7 adapter issue (`PrismaClientConstructorValidationError` on server start) would have been caught by running `npm run dev` before signaling M1 complete. The bug ended up in QA's bug-log, suggesting it was not caught by SE during self-review. PROGRESS.md states "All endpoints tested with curl" but this appears to be logged after CPE's fix, not before.
- **Root cause:** The self-verification checklist in SE AGENTS.md may not require explicitly running the dev server end-to-end before signaling. Or SE ran `npm run dev` but the Prisma error only surfaces when Prisma client initializes (on first API call), which might not have been hit during the scaffolding phase.
- **Finding type:** INSTANCE
- **Impact:** An unfixed build blocker shipped to CPE as "ready for QA." CPE had to absorb a diagnostic and fix cycle that should have been SE's responsibility.
- **Recommendation (instance):** Patch SE AGENTS.md §Self-Verification Checklist: add as a mandatory step: "Run `npm run dev` and make at least one successful API call to each endpoint before signaling complete. If the server fails to start, fix it before escalating."

---

## Positive Signals

- **Architect — delivery speed without quality sacrifice.** All three deliverables (ARCHITECTURE.md, PLANS.md, ExecPlan) completed in a single session on the same day as the handoff. Zero blocking of downstream work. The ExecPlan set a high standard: step-by-step shell commands, watch-outs, decision log, and acceptance criteria. This is the model for ExecPlan quality on every future mission.

- **UI/UX — thorough decision documentation.** The palette rationale document evaluated all five factory palettes with product-context reasoning, verified WCAG AA contrast ratios numerically, and documented future-proofing. MEMORY.md was fully updated with all decisions, discoveries, and open questions. This is the standard for design decision documentation.

- **CPE — handoff quality.** All four CPE handoffs are comprehensive and immediately actionable. The QA handoff is particularly strong: includes a 4-phase test protocol (happy path → edge cases → failure modes → regression), full endpoint spec, shell commands for the test environment, and clear success criteria. No downstream agent required clarification before starting work.

- **CPE — parallel execution decision.** Correctly identified that UI/UX and SE work were independent and launched both on 2026-05-07, preserving the tight timeline by eliminating a sequential bottleneck. This is the correct call and should be the default for design-and-implementation parallel tracks on all missions.

- **SE — API code quality.** The API implementation is clean and consistent. Error handling covers all cases per spec (400, 404, 409, 500). Tags JSON serialization/deserialization is handled uniformly across all routes. The export endpoint correctly sets Content-Disposition for file download. Modern Next.js 15 async params pattern is used correctly. For a day-one implementation on an aggressive timeline, the code is production-quality.

---

## Recommended AGENTS.md Changes

| Agent | File | Section | Change | Priority |
|-------|------|---------|--------|----------|
| SE | `.agents/software-engineer/AGENTS.md` | §Build Phase Protocol | Add explicit MEMORY.md update requirement during build phase | High |
| SE | `.agents/software-engineer/AGENTS.md` | §Architecture Compliance | Require logged decision + CPE signal for any deviation from ExecPlan schema/library/database | High |
| SE | `.agents/software-engineer/AGENTS.md` | §Self-Verification Checklist | Add mandatory: run `npm run dev` + make one call per endpoint before signaling complete | High |
| CPE | `.agents/cpe/AGENTS.md` | §Milestone Sign-Off Protocol | Verify all PLANS.md acceptance criteria before routing to QA — production deployment is required for M1 | High |
| CPE | `.agents/cpe/AGENTS.md` | §Blocker Resolution | When CPE resolves a bug directly: document fix in decisions/, update SE MEMORY.md, move bug to resolved/ | Medium |
| Architect | `.agents/architect/AGENTS.md` | §ExecPlan Standards | Specify local dev database setup explicitly; pin exact versions for ORM and database drivers | Medium |

---

## Pattern Learnings for agent-development skill

### Pattern 1: ExecPlan database setup ambiguity causes schema drift
When an ExecPlan specifies a production database (PostgreSQL) without an explicit local dev strategy, SE defaults to a pragmatic workaround (SQLite) that creates a schema mismatch between dev and production. The ExecPlan must answer: "What do you run locally and does it match production exactly?" If they differ, state the known schema differences and how to reconcile before production deploy.

### Pattern 2: CPE technical interventions create invisible gaps
When an orchestration agent resolves a technical issue directly (outside the standard build-verify-fix loop), the fix exists in production but not in the team's institutional memory. The implementation agent doesn't learn the fix, the bug ticket stays open, and no decision record exists. Every CPE technical intervention needs a three-step paper trail: decision log + agent MEMORY.md update + bug ticket closure.

---

## Eval Coverage Gap: UI/UX not in EVAL_CRITERIA.md

UI/UX Engineer is in the factory roster but has no scoring rubric in `EVAL_CRITERIA.md`. This mission demonstrates that UI/UX output quality varies meaningfully (the palette rationale and DESIGN_SYSTEM.md here are both excellent). Recommend CPE direct Eval to define UI/UX eval dimensions in EVAL_CRITERIA.md before M2 completes.

---

## Next Eval Checkpoint

**Recommended:** After QA completes M1 testing (expected 2026-05-08/09).

**Focus areas:**
1. **QA (first cycle):** Protocol adherence (4-phase test protocol), accuracy (does QA catch all endpoint edge cases), bug report quality
2. **SE (M1 QA loop):** If bugs are found, track whether SE fixes are at the root cause or are patches. Watch for same class of error recurring.
3. **Production deployment:** Verify Vercel deployment happens before M1 can be signed off. If it slips to M2, flag as a timeline risk.
4. **SE MEMORY.md:** Check if it's been updated before M2 starts. If still blank entering M2, escalate Protocol score to Watch.
